Clinical Relevance of Alternative Endpoints in Colorectal Cancer First-Line Therapy With Bevacizumab: A Retrospective Study.
Fiche publication
Date publication
mars 2018
Journal
Clinical colorectal cancer
Auteurs
Membres identifiés du Cancéropôle Est :
Dr PAGET-BAILLY Sophie
Tous les auteurs :
Turpin A, Paget-Bailly S, Ploquin A, Hollebecque A, Peugniez C, El-Hajbi F, Bonnetain F, Hebbar M
Lien Pubmed
Résumé
We studied the relationship between intermediate criteria and overall survival (OS) in metastatic colorectal cancer (mCRC) patients who received first-line chemotherapy with bevacizumab.
Mots clés
Alternative endpoints, Duration of disease control, Maintenance, Metastatic colorectal cancer, Time to failure of strategy
Référence
Clin Colorectal Cancer. 2018 Mar;17(1):e99-e107